Clicks Group Sells Unicorn Pharmaceuticals, Clears Path for New Licenses Amid Legal Resolution
- Clicks Group will sell its stake in Unicorn Pharmaceuticals to comply with a Constitutional Court judgment.
- The sale will allow the Department of Health to issue new retail pharmacy licenses to Clicks Group.
- The divestment supports Clicks Group’s expansion in providing accessible healthcare across South Africa.